SETD1A and hepatocellular carcinoma: In addition, the expression of SETD1A was obviously enhanced in hepatocellular carcinoma cell lines and tumor tissues and SETD1A knockdown enhanced sorafenib-induced proliferation inhibition and cellular apoptosis [15].